Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue

Biological Chemistry

Volumn 395, Issue 2, 2014, Pages 157-167

  Connolly, Diana ^a   Hoang, Hien G ^a   Adler, Esther ^a   Tazearslan, Cagdas ^a   Simmons, Nichelle ^b   Bernard, Vahni Vishala ^a   Castaldi, Maria ^b   Oktay, Maja H ^a   Montagna, Cristina ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b JACOBI MEDICAL CENTER   (United States)

Author keywords

Amplification; Breast cancer; Expression; Isoforms; Oncogene; Septin 9; Septins

Indexed keywords

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; EPITHELIAL CELLS; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; MIDDLE AGED; NEOPLASM GRADING; PROTEIN ISOFORMS; RNA, MESSENGER; SEPTINS;

EID: 84893811091     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2013-0247     Document Type: Article

References (43)

1. Amir, S. and Mabjeesh, N.J. (2007). SEPT9-V1 protein expression is associated with human cancer cell resistance to microtubule disrupting agents. Cancer Biol. Ther. 6, 1926-1931. (Pubitemid 351590405)
2. Amir, S., Golan, M., and Mabjeesh, N.J. (2010). Targeted knockdown of SEPT9-v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway. Mol. Cancer Res. 8, 643-652.
3. Burrows, J.F., Chanduloy, S., McIlhatton, M.A., Nagar, H., Yeates, K., Donaghy, P., Price, J., Godwin, A.K., Johnston, P.G., and Russell, S.E. (2003). Altered expression of the septin gene, SEPT9, in ovarian neoplasia. J. Pathol. 201, 581-588. (Pubitemid 38256407)
4. Cancer Genome Atlas Network. (2012). Comprehensive molecular portraits of human breast tumours. Nature 490, 61-70.
5. Cerami, E., Gao, J., Dogrusoz, U., Gross, B.E., Sumer, S.O., Aksoy, B.A., Jacobsen, A., Byrne, C.J., Heuer, M.L., Larsson, E., et al. (2012). The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2, 401-404.
6. Cerveira, N., Bizarro, S., and Teixeira, M.R. (2011). MLL-SEPTIN gene fusions in hematological malignancies. Biol. Chem. 392, 713-724.
7. Chacko, A.D., Hyland, P.L., McDade, S.S., Hamilton, P.W., Russell, S.H., and Hall, P.A. (2005). SEPT9-v4 expression induces morphological change, increased motility and disturbed polarity. J. Pathol. 206, 458-465. (Pubitemid 41025349)
8. Chacko, A.D., McDade, S.S., Chanduloy, S., Church, S.W., Kennedy, R., Price, J., Hall, P.A., and Russell, S.E. (2012). Expression of the SEPT9-i4 isoform confers resistance to microtubule-interacting drugs. Cell. Oncol. 35, 85-93.
9. Connolly, D., Abdesselam, I., Verdier-Pinard, P., and Montagna, C. (2011a). Septin roles in tumorigenesis. Biol. Chem. 392, 725-738.
10. Connolly, D., Yang, Z., Castaldi, M., Simmons, N., Oktay, M.H., Coniglio, S., Fazzari, M.J., Verdier-Pinard, P., and Montagna, C. (2011b). Septin 9 isoform expression, localization and epigenetic changes during human and mouse breast cancer progression. Breast Cancer Res. 13, R76.
11. deVos, T., Tetzner, R., Model, F., Weiss, G., Schuster, M., Distler, J., Steiger, K.V., Grutzmann, R., Pilarsky, C., Habermann, J.K., et al. (2009). Circulating methylated SEPT9 DNA in plasma is a biomarker for colorectal cancer. Clin. Chem. 55, 1337-1346.
12. Downing, T.E., Oktay, M.H., Fazzari, M.J., and Montagna, C. (2010). Prognostic and predictive value of 16p12.1 and 16q22.1 copy number changes in human breast cancer. Cancer Genet. Cytogenet. 198, 52-61.
13. Estey, M.P., Di Ciano-Oliveira, C., Froese, C.D., Bejide, M.T., and Trimble, W.S. (2010). Distinct roles of septins in cytokinesis: SEPT9 mediates midbody abscission. J. Cell. Biol. 191, 741-749.
14. Fan, C., Oh, D.S., Wessels, L., Weigelt, B., Nuyten, D.S., Nobel, A.B., van't Veer, L.J., and Perou, C.M. (2006). Concordance among gene-expression- based predictors for breast cancer. N. Engl. J. Med. 355, 560-569. (Pubitemid 44200649)
15. Foulkes, W.D. (2008). Inherited susceptibility to common cancers. N. Engl. J. Med. 359, 2143-2153.
16. Fuchtbauer, A., Lassen, L.B., Jensen, A.B., Howard, J., Quiroga Ade, S., Warming, S., Sorensen, A.B., Pedersen, F.S., and Fuchtbauer, E.M. (2011). Septin9 is involved in septin filament formation and cellular stability. Biol. Chem. 392, 769-777.
17. Golan, M. and Mabjeesh, N.J. (2013). SEPT9-i1 is required for the association between HIF-1αand importin-αto promote efficient nuclear translocation. Cell Cycle 12 (Epub ahead of print).
18. Gonzalez, M.E., Peterson, E.A., Privette, L.M., Loffreda-Wren, J.L., Kalikin, L.M., and Petty, E.M. (2007). High SEPT9-v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res. 67, 8554-8564. (Pubitemid 47437430)
19. Gonzalez, M.E., Makarova, O., Peterson, E.A., Privette, L.M., and Petty, E.M. (2009). Up-regulation of SEPT9-v1 stabilizes c-Jun-N-terminal kinase and contributes to its pro-proliferative activity in mammary epithelial cells. Cell. Signal. 21, 477-487.
20. Grutzmann, R., Molnar, B., Pilarsky, C., Habermann, J.K., Schlag, P.M., Saeger, H.D., Miehlke, S., Stolz, T., Model, F., Roblick, U.J., et al. (2008). Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay. PLoS One 3, e3759.
21. Hall, P.A. and Russell, S.E. (2004). The pathobiology of the septin gene family. J. Pathol. 204, 489-505. (Pubitemid 39468160)
22. Hall, P.A. and Russell, S.E. (2012). Mammalian septins: dynamic heteromers with roles in cellular morphogenesis and compartmentalization. J. Pathol. 226, 287-299.
23. Hall, P.A., Russell, S.E.H., and Pringle, J.R. (2008). The Septins (Wiley).
24. Kavallaris, M. (2010). Microtubules and resistance to tubulinbinding agents. Nat. Rev. Cancer 10, 194-204.
25. Kuhlenbaumer, G., Hannibal, M.C., Nelis, E., Schirmacher, A., Verpoorten, N., Meuleman, J., Watts, G.D., De Vriendt, E., Young, P., Stogbauer, F., et al. (2005). Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat. Genet. 37, 1044-1046. (Pubitemid 41486655)
26. Landsverk, M.L., Ruzzo, E.K., Mefford, H.C., Buysse, K., Buchan, J.G., Eichler, E.E., Petty, E.M., Peterson, E.A., Knutzen, D.M., Barnett, K., et al. (2009). Duplication within the SEPT9 gene associated with a founder effect in North American families with hereditary neuralgic amyotrophy. Hum. Mol. Genet. 18, 1200-1208.
27. Lofton-Day, C., Model, F., Devos, T., Tetzner, R., Distler, J., Schuster, M., Song, X., Lesche, R., Liebenberg, V., Ebert, M., et al. (2008). DNA methylation biomarkers for blood-based colorectal cancer screening. Clin. Chem. 54, 414-423. (Pubitemid 351302625)
28. McDade, S.S., Hall, P.A., and Russell, S.E. (2007). Translational control of SEPT9 isoforms is perturbed in disease. Hum. Mol. Genet. 16, 742-752. (Pubitemid 47061621)
29. McIlhatton, M.A., Burrows, J.F., Donaghy, P.G., Chanduloy, S., Johnston, P.G., and Russell, S.E. (2001). Genomic organization, complex splicing pattern and expression of a human septin gene on chromosome 17q25.3. Oncogene 20, 5930-5939. (Pubitemid 32937964)
30. Montagna, C., Lyu, M.S., Hunter, K., Lukes, L., Lowther, W., Reppert, T., Hissong, B., Weaver, Z., and Ried, T. (2003a). The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res. 63, 2179-2187. (Pubitemid 36538624)
31. Montagna, C., Lyu, M.S., Hunter, K., Lukes, L., Lowther, W., Reppert, T., Hissong, B., Weaver, Z., and Ried, T. (2003b). The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res. 63, 2179-2187. (Pubitemid 36538624)
32. Mostowy, S. and Cossart, P. (2012). Septins: the fourth component of the cytoskeleton. Nat. Rev. Mol. Cell. Biol. 13, 183-194.
33. Nagata, K., Kawajiri, A., Matsui, S., Takagishi, M., Shiromizu, T., Saitoh, N., Izawa, I., Kiyono, T., Itoh, T.J., Hotani, H., et al. (2003). Filament formation of MSF-A, a mammalian septin, in human mammary epithelial cells depends on interactions with microtubules. J. Biol. Chem. 278, 18538-18543. (Pubitemid 36799479)
34. Perou, C.M., Sorlie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., Rees, C.A., Pollack, J.R., Ross, D.T., Johnsen, H., Akslen, L.A., et al. (2000). Molecular portraits of human breast tumours. Nature 406, 747-752.
35. Peterson, E.A., Stanbery, L., Li, C., Kocak, H., Makarova, O., and Petty, E.M. (2011). SEPT9-i1 and genomic instability: mechanistic insights and relevance to tumorigenesis. Genes Chromosomes Cancer 50, 940-949.
36. Prat, A., Parker, J.S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J.I., He, X., and Perou, C.M. (2010). Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Res. 12, R68.
37. Scott, M., Hyland, P.L., McGregor, G., Hillan, K.J., Russell, S.E., and Hall, P.A. (2005). Multimodality expression profiling shows SEPT9 to be overexpressed in a wide range of human tumours. Oncogene 24, 4688-4700. (Pubitemid 41032605)
38. Scott, M., McCluggage, W.G., Hillan, K.J., Hall, P.A., and Russell, S.E. (2006). Altered patterns of transcription of the septin gene, SEPT9, in ovarian tumorigenesis. Int. J. Cancer 118, 1325-1329. (Pubitemid 43185625)
39. Sorlie, T., Perou, C.M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M.B., van de Rijn, M., Jeffrey, S.S., et al. (2001). Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869-10874. (Pubitemid 32878711)
40. Stanbery, L., D'Silva, N.J., Lee, J.S., Bradford, C.R., Carey, T.E., Prince, M.E., Wolf, G.T., Worden, F.P., Cordell, K.G., and Petty, E.M. (2010). High SEPT9-v1 expression is associated with poor clinical outcomes in head and neck squamous cell carcinoma. Transl. Oncol. 3, 239-245.
41. Sudo, K., Ito, H., Iwamoto, I., Morishita, R., Asano, T., and Nagata, K. (2007). SEPT9 sequence alternations causing hereditary neuralgic amyotrophy are associated with altered interactions with SEPT4/SEPT11 and resistance to Rho/Rhotekin-signaling. Hum. Mutat. 28, 1005-1013. (Pubitemid 47519393)
42. Surka, M.C., Tsang, C.W., and Trimble, W.S. (2002). The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis. Mol. Biol. Cell 13, 3532-3545. (Pubitemid 35191373)
43. The Ensembl project. Available at: ensembl.org.